HSBC Holdings’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
HSBC Holdings's PCVX Position: Q3 2026 in Review
HSBC Holdings sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 4,151 shares — an estimated $241K sold.
HSBC Holdings first reported a position in PCVX in Q2 2024 and held it in 9 quarters. The position peaked at $1.81M in Q3 2025. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- HSBC Holdings reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
- HSBC Holdings sold 4,151 Vaxcyte shares in Q3 2026, an estimated $241K.
- HSBC Holdings first reported a position in Vaxcyte in Q2 2024 and held it in 9 quarters.
- HSBC Holdings's Vaxcyte position peaked at $1.81M in Q3 2025.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.